Futura Medical (LON:FUM) Releases Quarterly Earnings Results

Futura Medical (LON:FUM) issued its quarterly earnings results on Tuesday. The company reported GBX (0.20) EPS for the quarter, Digital Look Earnings reports. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%.

Futura Medical Stock Down 1.8%

Shares of LON:FUM traded down GBX 0.01 during trading on Tuesday, reaching GBX 0.37. The stock had a trading volume of 22,394,688 shares, compared to its average volume of 9,153,882. The firm has a market capitalization of £2.17 million, a price-to-earnings ratio of -0.13 and a beta of 0.02. The stock has a fifty day simple moving average of GBX 0.42 and a two-hundred day simple moving average of GBX 0.79. Futura Medical has a 52 week low of GBX 0.24 and a 52 week high of GBX 10.45.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.